VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 10, 2007) - Med BioGene Inc. (TSX VENTURE:MBI), a life science company developing genetic biomarkers to improve screening, diagnosis, prognosis and treatment decisions for patients suffering from cancer and cardiovascular disease, is pleased to announce that it has engaged Peterson Capital of Vancouver to provide investor and financial relations services to MBI.
